ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Vaccinex Inc (PK)

Vaccinex Inc (PK) (VCNX)

1.00
0.00
(0.00%)
終了 6月8日 5:00AM

Vaccinex Inc (PK) (VCNX) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
1.00
( - )
買値
0.10
売値
3.00
出来高
109
1.00 日の範囲 1.00
0.31 52 週間の範囲 1.50
時価総額
前日終値
1.00
始値
1.00
時刻
1
@
1.1
最終取引時間
財務取引量
US$ 109
VWAP
1.00
平均取引量 (3 か月)
US$ 3,902
発行済株式数
2,676,637
配当利回り
PER
-0.11
1 株当たり利益 (EPS)
-8.88
歳入
601k
純利益
-18.63M

Vaccinex Inc (PK) について

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company’s lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks th... Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company’s lead drug candidate is pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. It is developing Pepinemab, which is in phase 2 clinical for the treatment of Alzheimer’s disease and has completed phase 2 study for the treatment of Huntington’s disease; Pepinemab in combination with Pembrolizumab in phase 2 study for head and neck cancer; Pepinemab in combination with Avelumab in phase 2 study for pancreatic cancer, and completed phase 2 clinical trial with Avelumab for non-small cell lung cancer; and Pepinemab in combination with Nivolumab and/or Ipilimumab which is in phase 2 clinical trial for melanoma; Pepinemab in combination with Trastuzumab and dendritic cell vaccines in phase 2 clinical trial for breast cancer. The company has also developed ActivMAb, a human antibody discovery platform based on a novel method for expressing and presenting complex multipass membrane proteins, as well as full-length human monoclonal antibodies on the surface of mammalian pox viruses. In addition, it develops CHS-114 and anti-CCR8 antibody; and VX5, which is in preclinical development to treat related to autoimmune disorders.It has collaborations with Merck Sharp & Dohme; Ares Trading S.A.; Emory University; Huntington Study Group; Catalent Pharma Solutions, LLC; and Surface Oncology, Inc. The company was incorporated in 2001 and is headquartered in Rochester, New York. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Rochester, United States
設立
2026
Vaccinex Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker VCNX. The last closing price for Vaccinex (PK) was US$1. Over the last year, Vaccinex (PK) shares have traded in a share price range of US$ 0.31 to US$ 1.50.

Vaccinex (PK) currently has 2,676,637 shares in issue. The market capitalisation of Vaccinex (PK) is US$2.68 million. Vaccinex (PK) has a price to earnings ratio (PE ratio) of -0.11.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10011.0220.761188050.97955632CS
4-0.4054-28.84588017651.40541.40540.761165230.99742349CS
120.38963.66612111290.6111.50.3442521.01182325CS
260.300542.95925661190.69951.50.3443201.03071013CS
520.2838.88888888890.721.50.3131350.91814652CS
156-0.4-28.57142857141.41.50.252138870.94359055CS
260-0.4-28.57142857141.41.50.252138870.94359055CS

VCNX - Frequently Asked Questions (FAQ)

What is the current Vaccinex Inc (PK) share price?
The current share price of Vaccinex Inc (PK) is US$ 1.00
How many Vaccinex Inc (PK) shares are in issue?
Vaccinex Inc (PK) has 2,676,637 shares in issue
What is the market cap of Vaccinex Inc (PK)?
The market capitalisation of Vaccinex Inc (PK) is USD 2.68M
What is the 1 year trading range for Vaccinex Inc (PK) share price?
Vaccinex Inc (PK) has traded in the range of US$ 0.31 to US$ 1.50 during the past year
What is the PE ratio of Vaccinex Inc (PK)?
The price to earnings ratio of Vaccinex Inc (PK) is -0.11
What is the cash to sales ratio of Vaccinex Inc (PK)?
The cash to sales ratio of Vaccinex Inc (PK) is 4.45
What is the registered address of Vaccinex Inc (PK)?
The registered address for Vaccinex Inc (PK) is 1895 Mount Hope Avenue, Rochester, New York, 14620
What is the Vaccinex Inc (PK) website address?
The website address for Vaccinex Inc (PK) is www.vaccinex.com
Which industry sector does Vaccinex Inc (PK) operate in?
Vaccinex Inc (PK) operates in the Biotechnology & Life Sciences sector

VCNX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock